Mouse PlGF

Slide this table

Size2 µg
Price90 €
SourceInsect cells
Purity Confirmation> 95% by SDS-PAGE
Length [aa]135/132
Molecular Weight~40 kDa
N Terminal SequenceALSAGNNSTE and AGNNSTE
Biological ActivityMeasured by its ability to bind to immobilized rh-sFlt-1 in a functional ELISA. Recombinant mouse PlGF can bind to immobilized rh-sFlt-1 (100 ng/well) with a linear range at 0.5 - 10 ng/mL.
Species ReactivityMouse
Buffer25 mM Tris, 75 mM NaCl pH 8.5
Stabilizer/CarrierBSA (50-fold)
ReconstitutionCentrifuge vial prior to opening. The lyophilised PlGF is supplied in lyophilized form with carrier-protein (BSA) and can be reconstituted with 50mM acetic acid or PBS/water. This solution can be diluted into other buffered solutions or stored frozen for future use.
Stability and StorageThe lyophilized mouse PIGF, though stable at room temperature, is best stored in working aliquots at -20°C to -70°C.
SynonymsPgf; PlGF; Plgf; AI854365; placental growth factor
DescriptionPlacenta growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF) family of growth factors. PlGF and VEGF share primary structural as well as limited amino acid sequence homology with the A and B chains of PDGF. All eight cysteine residues involved in intra and interchain disulfides are conserved among these growth factors. As a result of alternative splicing, three PlGF RNAs encoding monomeric human PlGF-1, PlGF-2 and PlGF-3 isoform precursors containing 149, 179 and 219 amino acid residues, respectively, have been described. In normal mouse tissues, only one mouse PlGF mRNA encoding the equivalent of human PlGF-2 has been identified. Mouse PlGF shares 65% amino acid identity with human PlGF-2. The gene for PlGF has been mapped to mouse chromosome 12 and human chromosome 14. PlGF binds with high affinity to Flt1, but not to Flk1/KDR.
Uniprot IDP49764
Protein RefSeqNP_032853
mRNA RefSeqNM_008827



  1. The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor. M. G. Atzori et al., Cancers (Basel). 2022 Nov; 14(22): 5578.

All prices plus VAT + possible delivery charges